Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Alabama › Birmingham
Qorannoo klinikaalii Kansaar Onnee Triple-Negative Birmingham, AL keessatti
Qorannoo 8 Kansaar Onnee Triple-Negative f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
PRE-ISPY Phase I/II Oncology Platform Program
Namoota walitti qabaa jiraSadarkaa 1/2
- The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center, Birmingham
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Alabama at Birmingham, Birmingham
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Namoota walitti qabaa jiraSadarkaa 3
- Alabama Oncology, Birmingham
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Namoota walitti qabaa jiraQorannoo ilaalaa
- Birmingham Hematology Associates, Birmingham
Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI)
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
- UAB, Birmingham
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Namoota walitti qabaa jiraSadarkaa 1
- Uni of Alabama at Birmingham, Birmingham
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- University of Alabama at Birmingham, Birmingham
- University of Alabama at Birmingham, IDS Pharmacy, Birmingham
- University of Alabama at Birmingham, Birmingham
- fi 1 dabalataa
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Alabama at Birmingham, Birmingham
Qorannoo Kansaar Onnee Triple-Negative magaalota biroo keessatti
- Houston, TXQorannoo 42
- New York City, NYQorannoo 31
- Nashville, TNQorannoo 28
- Los Angeles, CAQorannoo 27
- Boston, MAQorannoo 26
- San Antonio, TXQorannoo 23
- St. Louis, MOQorannoo 21
- Arlington, VAQorannoo 20
- Atlanta, GAQorannoo 20
- Dallas, TXQorannoo 18
- Chicago, ILQorannoo 16
- Columbus, OHQorannoo 16
Qorannoo biroo Birmingham keessatti
- Saree (Gosoota Hunda)Qorannoo 31
- Saree OljooQorannoo 24
- Kansarii OvariiQorannoo 23
- ObesityQorannoo 23
- Kansara Qara'a Non-Small CellQorannoo 22
- Leukemia Myeloidii HamaaQorannoo 21
- Myeloma Baay’eeQorannoo 18
- COPDQorannoo 17
- Dhibee Onneessaa fi DhiigaQorannoo 17
- Sukkaraa Gosa 2Qorannoo 16
- Kansa EndometiriyaaliiQorannoo 16
- Baayyee UlfaataaQorannoo 16
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.